Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Anti-Cancer Drugs|December 23, 2004
Cytotoxic effects of novel polyoxotungstates and a platinum compound on human cancer cell linesHans U V Gerth, Annette Rompel, Bernt Krebs, et al.Cancer Chemotherapy and Pharmacology|September 17, 2013
Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administrationMirjam N Trame, Imke H Bartelink, Joachim Boos, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 21, 2011
Pediatric patients with a malignant bone tumor: when does functional assessment make sense?Corinna Caroline Winter, Carsten Müller, Jendrik Hardes, et al.Cancer Chemotherapy and Pharmacology|May 27, 2010
Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugsDirk Heshe, Stephanie Hoogestraat, Christine Brauckmann, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 8, 2013
The effect of individualized exercise interventions during treatment in pediatric patients with a malignant bone tumorCorinna C Winter, Carsten Müller, Jendrik Hardes, et al.Pediatric Hematology and Oncology|July 10, 2014
Predictive performance of a physiologically based pharmacokinetic model of busulfan in childrenChristian Diestelhorst, Joachim Boos, Jeannine S McCune, et al.Anti-Cancer Drugs|September 27, 2006
In-vitro toxicity of Ukrain against human Ewing tumor cell linesClaudia Lanvers-Kaminsky, Dorothea-Maria Nolting, Julia Köster, et al.British Journal of Haematology|October 14, 2009
A population pharmacokinetic model for pegylated-asparaginase in childrenGeorg Hempel, Hans-Joachim Müller, Claudia Lanvers-Kaminsky, et al.Cancer Chemotherapy and Pharmacology|September 25, 2013
Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adultsChristian Diestelhorst, Joachim Boos, Jeannine S McCune, et al.Frontiers in Pediatrics|September 7, 2021
Adverse Events During Supervised Exercise Interventions in Pediatric Oncology-A Nationwide SurveyGabriele Gauß, Ronja Beller, Joachim Boos, et al.Pageof 10